1. Home
  2. PROK vs ALTO Comparison

PROK vs ALTO Comparison

Compare PROK & ALTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROK
  • ALTO
  • Stock Information
  • Founded
  • PROK 2015
  • ALTO 2003
  • Country
  • PROK United States
  • ALTO United States
  • Employees
  • PROK N/A
  • ALTO N/A
  • Industry
  • PROK Biotechnology: Biological Products (No Diagnostic Substances)
  • ALTO Major Chemicals
  • Sector
  • PROK Health Care
  • ALTO Industrials
  • Exchange
  • PROK Nasdaq
  • ALTO Nasdaq
  • Market Cap
  • PROK 126.8M
  • ALTO 123.0M
  • IPO Year
  • PROK N/A
  • ALTO N/A
  • Fundamental
  • Price
  • PROK $1.02
  • ALTO $0.90
  • Analyst Decision
  • PROK Buy
  • ALTO Strong Buy
  • Analyst Count
  • PROK 4
  • ALTO 1
  • Target Price
  • PROK $5.00
  • ALTO $5.50
  • AVG Volume (30 Days)
  • PROK 1.3M
  • ALTO 510.1K
  • Earning Date
  • PROK 05-09-2025
  • ALTO 05-05-2025
  • Dividend Yield
  • PROK N/A
  • ALTO N/A
  • EPS Growth
  • PROK N/A
  • ALTO N/A
  • EPS
  • PROK N/A
  • ALTO N/A
  • Revenue
  • PROK $76,000.00
  • ALTO $965,258,000.00
  • Revenue This Year
  • PROK N/A
  • ALTO N/A
  • Revenue Next Year
  • PROK N/A
  • ALTO $5.90
  • P/E Ratio
  • PROK N/A
  • ALTO N/A
  • Revenue Growth
  • PROK N/A
  • ALTO N/A
  • 52 Week Low
  • PROK $0.46
  • ALTO $0.76
  • 52 Week High
  • PROK $4.44
  • ALTO $2.05
  • Technical
  • Relative Strength Index (RSI)
  • PROK 60.91
  • ALTO 39.70
  • Support Level
  • PROK $0.66
  • ALTO $0.77
  • Resistance Level
  • PROK $0.89
  • ALTO $0.90
  • Average True Range (ATR)
  • PROK 0.17
  • ALTO 0.06
  • MACD
  • PROK 0.06
  • ALTO 0.02
  • Stochastic Oscillator
  • PROK 77.78
  • ALTO 91.17

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.

About ALTO Alto Ingredients Inc.

Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.

Share on Social Networks: